Heather A. Berger serves as Executive at Entasis Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Heather A. Berger has executed 3 insider transactions totaling $4.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 25, 2024 involved purchasing 1,300 shares valued at $4.9K.
Heather A. Berger currently holds 1,300 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Heather A. Berger has been a net buyer of ETTX stock. They have purchased $4.9K and sold $0 worth of shares.
Heather A. Berger's most recent insider trade was on Mar 25, 2024, when they purchased 1,300 shares at $3.74 per share.
Get notified when new Form 4 filings are submitted
| $2.20 |
| Discretionary |
| Jul 7, 2022 | ETTX | $48.4K | Tender | 22,000 | $2.20 | Discretionary |